SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-008630
Filing Date
2024-03-19
Accepted
2024-03-19 18:06:26
Documents
1
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 form4-03192024_100308.html 4  
1 form4-03192024_100308.xml 4 9680
  Complete submission text file 0001415889-24-008630.txt   11134
Mailing Address 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Winningham Rick E (Reporting) CIK: 0001302443 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 24765400

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)